Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Axial Spondyloarthritis to Musculoskeletal Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Axial Spondyloarthritis to Musculoskeletal Disorders Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Axial Spondyloarthritis Therapeutics Clinical Trials 35
Prominent Drugs 37
Clinical Trial Profile Snapshots 38
Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 107
About GlobalData 107
Contact Us 108
Source 108

List of Tables
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Region, 2018* 7
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Axial Spondyloarthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Axial Spondyloarthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Axial Spondyloarthritis Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Axial Spondyloarthritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Axial Spondyloarthritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Axial Spondyloarthritis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2018* 17
Axial Spondyloarthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Axial Spondyloarthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Axial Spondyloarthritis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2018* 22
Axial Spondyloarthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Axial Spondyloarthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 25
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Phase, 2018* 26
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 27
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 29
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31
Axial Spondyloarthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 32
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 34
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 36
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37

List of Figures
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Axial Spondyloarthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Axial Spondyloarthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Axial Spondyloarthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Axial Spondyloarthritis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15
Proportion of Axial Spondyloarthritis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2018* 16
Axial Spondyloarthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Axial Spondyloarthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Axial Spondyloarthritis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2018* 21
Axial Spondyloarthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Axial Spondyloarthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 26
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 27
Axial Spondyloarthritis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31
Axial Spondyloarthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 32
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Axial Spondyloarthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37
GlobalData Methodology 107

Companies Mentioned
- UCB SA
- AbbVie Inc
- Novartis AG
- Pamplona Capital Management LLP
- Pfizer Inc
- Merck & Co Inc
- Eli Lilly and Co
- Johnson & Johnson
- Amgen Inc
- Abbott Laboratories